These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 37376531)

  • 41. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.
    Zhang J; Garrett S; Sun J
    Genes Dis; 2021 Jul; 8(4):385-400. PubMed ID: 33521210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastrointestinal manifestations and SARS-CoV-2 infection.
    Pizuorno A; Brim H; Ashktorab H
    Curr Opin Pharmacol; 2021 Dec; 61():114-119. PubMed ID: 34688995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastrointestinal manifestations in COVID-19.
    Kariyawasam JC; Jayarajah U; Riza R; Abeysuriya V; Seneviratne SL
    Trans R Soc Trop Med Hyg; 2021 Dec; 115(12):1362-1388. PubMed ID: 33728439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
    Viana SD; Nunes S; Reis F
    Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Impact of COVID-19 in Gastroenterology and Hepatology.
    Ramkissoon R; Wang XJ
    J Clin Gastroenterol; 2021 Oct; 55(9):757-765. PubMed ID: 34420001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management.
    Mohamed DZ; Ghoneim ME; Abu-Risha SE; Abdelsalam RA; Farag MA
    World J Gastroenterol; 2021 Jul; 27(28):4504-4535. PubMed ID: 34366621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 - gastrointestinal and gut microbiota-related aspects.
    Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions.
    Norouzi Masir M; Shirvaliloo M
    JGH Open; 2022 Aug; 6(10):667-76. PubMed ID: 36247234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection.
    Dvornikova KA; Bystrova EY; Churilov LP; Lerner A
    Mol Biol Rep; 2021 Jul; 48(7):5745-5758. PubMed ID: 34296352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digestive system manifestations and clinical significance of coronavirus disease 2019: A systematic literature review.
    Ye L; Yang Z; Liu J; Liao L; Wang F
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1414-1422. PubMed ID: 33150978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastrointestinal coronavirus disease 2019 manifestations in childhood.
    Sansotta N; Norsa L; D'Antiga L
    Curr Opin Clin Nutr Metab Care; 2022 May; 25(3):195-202. PubMed ID: 35199658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal Manifestations of COVID-19: Impact on Nutrition Practices.
    Aguila EJT; Cua IHY; Fontanilla JAC; Yabut VLM; Causing MFP
    Nutr Clin Pract; 2020 Oct; 35(5):800-805. PubMed ID: 32668037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas.
    Khreefa Z; Barbier MT; Koksal AR; Love G; Del Valle L
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronavirus disease-2019 and the intestinal tract: An overview.
    Alberca GGF; Solis-Castro RL; Solis-Castro ME; Alberca RW
    World J Gastroenterol; 2021 Apr; 27(13):1255-1266. PubMed ID: 33833480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposal.
    Tao SS; Wang XY; Yang XK; Liu YC; Fu ZY; Zhang LZ; Wang ZX; Ni J; Shuai ZW; Pan HF
    J Med Virol; 2022 Dec; 94(12):5640-5652. PubMed ID: 35971954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 and gastrointestinal system: A brief review.
    Pola A; Murthy KS; Santhekadur PK
    Biomed J; 2021 Jun; 44(3):245-251. PubMed ID: 34130944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 and the Gastrointestinal Tract in Children.
    Puoti MG; Rybak A; Kiparissi F; Gaynor E; Borrelli O
    Front Pediatr; 2021; 9():617980. PubMed ID: 33692973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19.
    Jones DL; Baluja MQ; Graham DW; Corbishley A; McDonald JE; Malham SK; Hillary LS; Connor TR; Gaze WH; Moura IB; Wilcox MH; Farkas K
    Sci Total Environ; 2020 Dec; 749():141364. PubMed ID: 32836117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
    Galanopoulos M; Doukatas A; Gazouli M
    World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.